Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001415889-25-001160

Options or other derivatives

  • Director acquired 35,274 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Senner Christopher J. Director 2025-01-02 Grant or award · Director Stock Option (right to buy) +35,274 35,274 D
Loading xslF345X05/form4-01092025_120111.xml…